AplaGen GmbH and Lonza Ltd have signed a licensing agreement for AplaGen's CFPS-Technology
12-May-2004 -
Lonza Ltd, Switzerland, and AplaGen, Germany closed a combined cooperation and licensing agreement for AplaGen's "CFPS"-Technology (correctly folded peptide synthesis), a new and emerging method for the synthesis of longer mer peptides and proteins.
Today peptides and proteins are ...
business development
infectious diseases
Lonza
+5